Drug Design and Optimization Lab
From Wikipedia, the free encyclopedia
Drug Design and Optimization Lab better known as "D2OL" was a Distributed Computing project with the goal of discovering drug candidates to fight SARS, Anthrax, Smallpox and other diseases and is currently being hosted by The Rotherberg Institute. The project ended on April 15, 2009.
[edit] See also
- Community TSC — project developed by the Rothberg Institute For Childhood Diseases that uses the D2OL architecture.
- List of distributed computing projects
- Molecular modelling
[edit] External links
 |
This scientific software article is a stub. You can help Wikipedia by expanding it. |
